Paid Clinical Trials in Irving, TX

As of June 2026, 113 paid clinical trials are recruiting in Irving, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 18, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

113 clinical trials

↓ Download CSV

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

for Locally Advanced or Metastatic Solid Tumors

10 locations incl. Los Angeles

Sponsor: ArriVent BioPharma, Inc.

Sex: All·Age: 18+

Code: NCT07066657·Phase 1·Recruiting

Apply to this trial

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

for Solid Tumor

11 locations incl. Santa Monica

Sponsor: Astellas Pharma Inc

Sex: All·Age: 18+

Code: NCT07094204·Phase 1·Recruiting

Apply to this trial

A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)

for Bipolar Disorder Type I With Mania

Drug: KarXT

52 locations incl. Glendale

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 65

Code: NCT06929273·Phase 3·Recruiting

Apply to this trial

A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)

for Eczema Atopic Dermatitis

1 location in Irving

Sponsor: Turn Therapeutics

Sex: All·Age: 18 - 80

Code: NCT07355075·Phase 2·Recruiting

Apply to this trial

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

for Refractory Rheumatoid Arthritis (RA)

Drug: Rituximab

31 locations incl. Tuscaloosa

Sponsor: Artiva Biotherapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06991114·Phase 2·Recruiting

Apply to this trial

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

for Breast Cancer

134 locations incl. Daphne

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06966453·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for Graves' Disease

Drug: IMVT-1402

33 locations incl. Tucson

Sponsor: Immunovant Sciences GmbH

Sex: All·Age: 18 - 75

Code: NCT07018323·Phase 2·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

for Major Depressive Disorder (MDD)

28 locations incl. Chino

Sponsor: Seaport Therapeutics

Sex: All·Age: 18 - 65

Code: NCT07065240·Phase 2·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder

for Bipolar-I Disorder With Mania or Mania With Mixed Features

Drug: KarXT

22 locations incl. Bentonville

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18 - 65

Code: NCT06951698·Phase 3·Recruiting

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

315 locations incl. Athens

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting

Apply to this trial

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for PDAC

18 locations incl. Scottsdale

Sponsor: Tango Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06922591·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

for Heart Failure

Drug: Empagliflozin

105 locations incl. Mobile

Sponsor: Boehringer Ingelheim

Sex: All·Age: 18+

Code: NCT06935370·Phase 3·Recruiting

Apply to this trial

Study of GS-0151 in Participants With Rheumatoid Arthritis

for Rheumatoid Arthritis

18 locations incl. Anniston

Sponsor: Gilead Sciences

Sex: All·Age: 18 - 75

Code: NCT06902519·Phase 1·Recruiting

Apply to this trial

Randomized Withdrawal Study in Patients With Schizophrenia

for Schizophrenia

22 locations incl. Rogers

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06961968·Phase 3·Recruiting

Apply to this trial

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

7 locations incl. Scottsdale

Sponsor: Tagworks Pharmaceuticals BV

Sex: All·Age: 18+

Code: NCT06959706·Phase 1·Recruiting

Apply to this trial

STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

for Solid Tumor

6 locations incl. Lake Success

Sponsor: STORM Therapeutics LTD

Sex: All·Age: 18+

Code: NCT06975293·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

for Solid Tumors

6 locations incl. Pheonix

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Sex: All·Age: 18 - 75

Code: NCT06963281·Phase 1·Recruiting

Apply to this trial

A Study of PHST001 in Advanced Solid Tumors

for Advanced Solid Tumors

20 locations incl. Beverly Hills

Sponsor: Pheast Therapeutics

Sex: All·Age: 18+

Code: NCT06840886·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

for Advanced Solid Tumors

7 locations incl. Birmingham

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT06818643·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

for MTAP-deleted Solid Tumors

17 locations incl. Birmingham

Sponsor: Bayer

Sex: All·Age: 18+

Code: NCT06914128·Phase 1, Phase 2·Recruiting

Apply to this trial

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for Solid Tumor

13 locations incl. Denver

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06874335·Phase 1·Recruiting

Apply to this trial

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

for Psoriatic Arthritis

Drug: Tirzepatide

53 locations incl. Avondale

Sponsor: Eli Lilly and Company

Sex: All·Age: 18+

Code: NCT06864026·Phase 4·Recruiting

Apply to this trial

A Phase 1 Study of IM-1021 in Participants With Advanced Cancer

for Solid Malignancies

12 locations incl. Duarte

Sponsor: Immunome, Inc.

Sex: All·Age: 18+

Code: NCT06823167·Phase 1·Recruiting

Apply to this trial

A Study of HS-20110 in Participants With Advanced Solid Tumors

for Solid Tumors

7 locations incl. Tamarac

Sponsor: Hansoh BioMedical R&D Company

Sex: All·Age: 18+

Code: NCT06892379·Phase 1·Recruiting

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

7 locations incl. Grand Rapids

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06804824·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

for Lung Cancer

14 locations incl. Birmingham

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT06618287·Phase 1, Phase 2·Recruiting

Apply to this trial

An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

11 locations incl. Los Angeles

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06589596·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

for Arthritis, Psoriatic

23 locations incl. Glendale

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT06807424·Phase 3·Recruiting

Apply to this trial

Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution

for Congenital Myasthenic Syndrome

2 locations incl. Naples

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine

Sex: All·Age: 18+

Code: NCT07226726·Phase 1·Recruiting

Apply to this trial

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

12 locations incl. New Haven

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06657222·Phase 1, Phase 2·Recruiting

Apply to this trial

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC

for Non-squamous Non-small Cell Lung Cancer

Drug: Rilvegostomig

77 locations incl. Mobile

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06627647·Phase 3·Recruiting

Apply to this trial

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

for Systemic Lupus Erythematosus

61 locations incl. Avondale

Sponsor: UCB Biopharma SRL

Sex: All·Age: 16+

Code: NCT06617325·Phase 3·Recruiting

Apply to this trial

Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial

for Chronic Kidney Disease

25 locations incl. San Francisco

Sponsor: George Washington University

Sex: All·Age: 65+

Code: NCT06243068·Enrolling By Invitation

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

for Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

6 locations incl. La Palma

Sponsor: DualityBio Inc.

Sex: All·Age: 18 - 70·Accepts healthy volunteers

Code: NCT06625671·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

for Metastatic HER2-positive Breast Cancer

48 locations incl. Phoenix

Sponsor: Jazz Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06435429·Phase 3·Recruiting

Apply to this trial

Study of APR-1051 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

3 locations incl. Houston

Sponsor: Aprea Therapeutics

Sex: All·Age: 18+

Code: NCT06260514·Phase 1·Recruiting

Apply to this trial

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for Ovarian Cancer

7 locations incl. Birmingham

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06303505·Phase 1, Phase 2·Recruiting

Apply to this trial

Safety, Tolerability, and Pharmacokinetics of DCR-PDL1 in Adults With Solid Tumors

for Solid Tumors, Adult

2 locations incl. Irving

Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Sex: All·Age: 18+

Code: NCT06504368·Phase 1·Recruiting

Apply to this trial

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

for Colorectal Cancer

32 locations incl. Chandler

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT06445062·Phase 1, Phase 2·Recruiting

Apply to this trial

A Phase I Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors

for Advanced Solid Tumors

11 locations incl. Aurora

Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

Sex: All·Age: 18+

Code: NCT06384352·Phase 1·Recruiting

Apply to this trial